3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
55
Ovarian Neoplasms
39
Carcinoma, Hepatocellular
39
Neoplasms
25
Fallopian Tube Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Endometrial Neoplasms
14
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Colonic Neoplasms
10
Neoplasm Metastasis
9
Lung Neoplasms
8
Liver Neoplasms
8
Uterine Cervical Neoplasms
7
Stomach Neoplasms
6
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms, Nerve Tissue
3
Gastrointestinal Neoplasms
3
Interventions
Fulvestrant
4
ribociclib
2
palbociclib
2
Irinotecan
2
Gemcitabine
2
venetoclax
1
tivozanib
1
serabelisib
1
sapanisertib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
STX-478
1
Paclitaxel
1
Metformin
1
Lomustine
1
Letrozole
1
Imlunestrant
1
Doxorubicin
1
Cetuximab
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Bevacizumab
×
90 days
×
Clear all
No trials found.